Thymidine phosphorylase suppresses apoptosis induced by microtubule-interfering agents

被引:32
作者
Jeung, HC
Che, XF
Haraguchi, M
Furukawa, T
Zheng, CL
Sumizawa, T
Rha, SY
Roh, JK
Akiyama, S
机构
[1] Kagoshima Univ, Dept Mol Oncol, Grad Sch Med & Dent Sci, Kagoshima 8908520, Japan
[2] Yonsei Univ, Coll Med, Canc Metastasis Res Ctr, Seoul 120752, South Korea
关键词
thymidine phosphorylase; microtubule; apoptosis; experimental therapeutics;
D O I
10.1016/j.bcp.2005.04.017
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We investigated the ability of thymidine phosphorylase (TP) to confer cancer cells resistance to MIA (microtubule-interfering agents)-induced apoptosis. Jurkat cells were stably transfected with TP cDNA (Jurkat/TP) and the sensitivity to MIAs were examined. Jurkat/TP cells were more resistant to apoptosis induced by nocodazole, vincristine, vinblastine, paclitaxel and 2-metboxyestradiol than mock-trasfected Jurkat/CV cells. TP enzymatic activity was not required for this effect of TP. Jurkat/TP cells showed weak phosphorylation of Bcl-2, and kinase inhibitors staurosporine and genistein attenuated not only MIA-induced Bcl-2 phosphorylation but also cytotoxicity of MIA in Jurkat/CV, but not in Jurkat/TP. MIAs diminished expression of FasL in Jurkat/TP but not in Jurkat/CV, and neutralization of FasL by anti-FasL antibody considerably attenuated the cytotoxic effect of the MIAs in Jurkat/CV, but the effect of the antibody was marginal in Jurkat/TP cells. Our study provides further evidence that TP functions in conferring resistance on cancer cells to the stress induced by MIAs. In addition, we show that TP-induced inhibition of Bcl-2 phosphorylation and suppression of FasL may contribute to the protective function of TP in cancer cells. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:13 / 21
页数:9
相关论文
共 29 条
  • [1] Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells
    Blagosklonny, MV
    Chuman, Y
    Bergan, RC
    Fojo, T
    [J]. LEUKEMIA, 1999, 13 (07) : 1028 - 1036
  • [2] Blagosklonny MV, 1997, CANCER RES, V57, P130
  • [3] Blagosklonny MV, 1996, CANCER RES, V56, P1851
  • [4] Haldar S, 1996, CANCER RES, V56, P1253
  • [5] Thymidine phosphorylase and 2-deoxyribose stimulate human endothelial cell migration by specific activation of the integrins α5β1 and αVβ3
    Hotchkiss, KA
    Ashton, AW
    Schwartz, EL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (21) : 19272 - 19279
  • [6] Thymidine phosphorylase inhibits apoptosis induced by cisplatin
    Ikeda, R
    Furukawa, T
    Mitsuo, R
    Noguchi, T
    Kitazono, M
    Okumura, H
    Sumizawa, T
    Haraguchi, M
    Che, XF
    Uchimiya, H
    Nakajima, Y
    Ren, XQ
    Oiso, S
    Inoue, I
    Yamada, K
    Akiyama, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 301 (02) : 358 - 363
  • [7] Molecular basis for the inhibition of hypoxia-induced apoptosis by 2-Deoxy-D-ribose
    Ikeda, R
    Furukawa, T
    Kitazono, M
    Ishitsuka, K
    Okumura, H
    Tani, A
    Sumizawa, T
    Haraguchi, M
    Komatsu, M
    Uchimiya, H
    Ren, XQ
    Motoya, T
    Yamada, K
    Akiyama, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 291 (04) : 806 - 812
  • [8] KINETIC-STUDIES OF THYMIDINE PHOSPHORYLASE FROM MOUSE-LIVER
    ILTZSCH, MH
    ELKOUNI, MH
    CHA, S
    [J]. BIOCHEMISTRY, 1985, 24 (24) : 6799 - 6807
  • [9] Prevention of hypoxia-induced apoptosis by the angiogenic factor thymidine phosphorylase
    Kitazono, M
    Takebayashi, Y
    Ishitsuka, K
    Takao, S
    Tani, A
    Furukawa, T
    Miyadera, K
    Yamada, Y
    Aikou, T
    Akiyama, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 253 (03) : 797 - 803
  • [10] Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases)
    Los, M
    Herr, I
    Friesen, C
    Fulda, S
    SchulzeOsthoff, K
    Debatin, KM
    [J]. BLOOD, 1997, 90 (08) : 3118 - 3129